BackBotanix Pharmaceuticals Limited Overview

Botanix Pharmaceuticals Limited Net Tangible Assets

Track Botanix Pharmaceuticals Limited's net tangible assets ($63M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$63.43M
↓ 21.98% YoYΔ $-17.87M vs prior year quarter

Peer trimmed avg / median

Loading

Botanix Pharmaceuticals Limited Net Tangible Assets History

Loading

Botanix Pharmaceuticals Limited vs. peers: Net Tangible Assets Comparison

Loading

Botanix Pharmaceuticals Limited Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Botanix Pharmaceuticals Limited (BOT.AX) FAQ

As of the most recent data (June 2026), BOT.AX shows a net tangible assets of $63M. That compares with $81M in the prior-year period — down 22.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BOT.AX's net tangible assets is now $63M (was $81M) — a 22.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Botanix Pharmaceuticals Limited is outperforming or lagging.

Tracking BOT.AX's net tangible assets over time shows whether Botanix Pharmaceuticals Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $63M That compares with $81M in the prior-year period — down 22.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Botanix Pharmaceuticals Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $63M) with ownership activity and broader fundamentals.

Botanix Pharmaceuticals Limited's net tangible assets is $63M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.